The Best Timing for Medical Business Succession | 5 Judgment Criteria and Preparation Period

📖 Approx. 9 minPublished: 2026.05.05 ／ Updated 2026.05.08

When is the Optimal Timing for Medical Business Succession?

One of the most pressing questions for clinic directors and chairpersons of medical corporations is, “When is the best time for medical business succession?” Moving too early or too late can negatively impact crucial factors such as the sale price, staff treatment, and successor selection. Particularly for medical corporations, their unique nature necessitates consideration from a perspective distinct from general business succession. In this article, M&A Medical, specializing in medical M&A and business succession, presents five judgment criteria based on experience and explains the specific points for determining the optimal timing. We hope this serves as a guide for achieving a succession without regret, considering the perspectives of both clinic directors and their consulting tax accountants and CPAs.

Accounts for approx. 60% (Source: Based on Ministry of Health, Labour and Welfare surveys of medical facilities, etc.)

1. The Importance of Timing in Medical Business Succession

Medical M&A and business succession involve numerous unique considerations compared to general businesses, such as the transfer of licenses and permits, the impact of medical fee revisions, and alignment with regional medical plans. Taking these factors into account, the process from consultation to the actual M&A contract (closing) typically takes six months to a year, and sometimes even longer. Furthermore, considering the post-merger integration (PMI) period, it is advisable to start preparations at least two to three years, and ideally three to five years, before the director or chairperson plans to retire. Proceeding with succession without sufficient preparation time or at the wrong time significantly increases the risk of the following issues:

• Reduced Sale Price: If the business performance deteriorates, medical equipment becomes obsolete, or patients leave, the sale price will naturally be much lower than anticipated. Particularly, immediately after significant investment in new equipment, the buyer faces increased initial investment burdens, which can lead to difficult price negotiations.
• Limited Successor Options: Finding a successor within the organization or from external candidates takes time. If the search for candidates begins close to the retirement date, there’s a risk that their schedules or desired conditions may not align, narrowing the available options.
• Staff Anxiety and Turnover: If news of the succession plan leaks before it’s officially announced, it can cause anxiety among staff, potentially leading to resignations. The departure of long-term employees or highly specialized staff is particularly concerning, as it can impact the quality of care and patient services.
• Missed Opportunities for Tax and Inheritance Planning: For certain corporate structures, such as medical corporations with equity interests, significant reductions in future inheritance tax burdens may be possible through measures like equity restructuring or lifetime gifts before the inheritance occurs. However, missing the optimal timing for succession can eliminate these opportunities for tax optimization.

To avoid these risks and achieve a smooth business succession under favorable terms, strategic and planned timing is extremely important.

2. Five Criteria for Determining the Best Timing

Determining the optimal timing for medical business succession requires a comprehensive assessment of multiple factors, not just a single indicator. Here, we will discuss five key judgment criteria that directors and chairpersons should pay particular attention to.

2-1. Age and Health Condition of the Director/Chairperson

Generally, a good time to start considering a medical M&A is when the director or chairperson is in their late 60s to early 70s. This is often when individuals begin to seriously contemplate passing on their legacy to the next generation. Crucially, one’s health condition is important. Being in good health and having the energy to engage in negotiations can lead to better terms. If health issues arise, forcing a sudden or unavoidable sale, the risk of a significantly lower sale price increases. Furthermore, for medical corporations, procedures related to the change of chairperson must also be considered.

2-2. Performance Trends of the Clinic/Medical Corporation

The valuation for business succession is typically based on EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) over the last three to five years or on future cash flow projections. Therefore, it is ideal for the business to be in a stable, growing, or near-peak performance state at the time of succession. If M&A is considered when performance is already declining or shows a significant downward trend, it is highly likely to negatively impact the sale price. It is important to assess performance stability and growth potential from a medium-to-long-term perspective, including the impact of medical fee revisions and competitor trends.

2-3. Condition and Future Plans for Facilities and Buildings

The timing for medical equipment renewal, interior renovation plans, and the expiration of building lease agreements are also important factors to consider when determining the timing of business succession. For instance, if expensive medical equipment has been recently installed, the buyer may face difficulties in price negotiations due to the increased burden of recouping the initial investment. Conversely, if major repairs or renovations of aging facilities and buildings are imminent, how these costs will be handled becomes a focal point of the transfer agreement. Lease expiration dates are also crucial for the buyer as they directly impact ongoing operational costs. It is essential to consider these future plans and investment cycles related to facilities and buildings to identify a timing that minimizes the burden on the buyer while maintaining the quality of medical care.

2-4. Availability and Status of Successor Candidates and Consideration of Third-Party Succession

The most ideal scenario for medical institution succession is within the family or to a practicing physician within the organization. However, the shortage of successors has become a serious issue in recent years, leading to an increase in third-party successions, i.e., business succession through M&A. Even if there are successor candidates within the organization, their motivation, capabilities, and the time required for succession must be considered. If no suitable internal candidate is found, or if training a candidate would take too long, it is important to look towards the external M&A market early on. External candidates can include a diverse range of players, such as competitors, new entrants from other industries, and investment funds. Instead of rushing into negotiations after finding a candidate, it is key to consider multiple options, understand the objective market value, and make decisions at the optimal time to secure more favorable terms.

2-5. Tax and Inheritance Situation and Corporate Form

There are two types of medical corporations: those with equity interests and those without. Particularly for medical corporations with equity interests, the assessed value of the equity is subject to inheritance tax. As directors and board members age, there is a significant opportunity to reduce future inheritance tax burdens by systematically restructuring equity or utilizing lifetime gifts before an inheritance occurs. Furthermore, for medical corporations, there are unique issues beyond the valuation of equity interests, such as the refund of funds and resolutions at general meetings of members. These tax and inheritance planning measures require specialized knowledge, making early collaboration with experts like tax accountants and CPAs essential to consider the optimal scheme tailored to the corporate form and individual circumstances. The timing of business succession can also serve as a criterion for effectively implementing these tax and inheritance measures.

Comparison of Clinic Closure and Business Succession

Item	Closure (Business Cessation)	Business Succession (M&A)
Sale Price (Assets)	Demolition and disposal costs incurred.	Valued based on profitability and asset value of the clinic/medical corporation; capital gains may arise.
Staff Treatment	Generally, dismissal or voluntary resignation.	Employment continuation generally expected; treatment may be maintained or improved through negotiation.
Impact on Patients	Loss of access to care, burden of finding new clinics nearby.	Continuous medical care possible; contributes to maintaining regional healthcare.
Licenses and Equipment	All become void or are disposed of.	Generally transferred to the buyer; licensing procedures are required.
Post-Retirement for Director/Chairperson	May involve significant financial and emotional burdens.	Can receive proceeds from succession; sense of contribution to the region may persist.

3. Specific Process and Timeline for Initiating M&A Consideration

Understanding the M&A process and the time it requires is crucial for gauging the timing of business succession. As mentioned earlier, medical institution M&A tends to take longer than general business transactions due to its specific nature. Below is an outline of the standard process supported by M&A Medical and an estimated timeline for each step. Grasping this entire process and working backward from your desired retirement or succession date is key to successful planning.

1. Free Consultation & Initial Hearing (30-60 minutes):First, please share your concerns and wishes regarding business succession. Our specialists will carefully listen to your clinic’s situation and provide advice on the possibilities and procedures for M&A.

2. Execution of Non-Disclosure Agreement (NDA) & Business Valuation (1-2 weeks):Based on mutual trust, an NDA will be executed. Subsequently, an objective business valuation (preliminary assessment) will be conducted based on your clinic’s financial status and business operations.

3. Search for M&A Candidates & Matching (1-3 months):Leveraging our network, we will search for and select potential buyers that match your criteria. We will introduce suitable candidates as soon as they are identified.

4. Meetings & Letter of Intent (LOI) Execution (1-2 months):Through meetings with potential candidates, we will align management visions and terms. Upon reaching a basic agreement, an LOI will be executed, defining terms such as exclusivity.

5. Due Diligence (DD) & Share Purchase Agreement (SPA) Execution (2-3 months):The buyer will conduct a detailed investigation (DD) of your clinic’s finances, legal aspects, and business operations. Based on the DD results, the final Share Purchase Agreement (SPA) will be executed.

6. Closing & PMI (Ongoing):Based on the agreement, payment and transfer of rights will occur. Subsequently, smooth Post-Merger Integration (PMI) will be pursued to ensure the continuation and development of the business.

It is extremely important to keep in mind that this entire process generally takes 6 months to a year, or sometimes longer, and to set a preparation period with ample buffer time.

Medical business succession is not merely a “sale”; it is a vital process of passing on the passion for medicine and contribution to the community, cultivated over many years, to the next generation. Let us achieve a succession without regret at the optimal timing, together with a trusted partner. M&A Medical offers free consultations for medical institution business succession at any time. Please feel free to contact us.

---

Consult M&A Medical for Medical Succession

M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the successful transfer of clinics and medical corporations facing successor shortages, as well as strategic acquisitions, on a success-fee basis.

• Initial consultation and preliminary assessment are free
• No retainer or monthly fees (success fee only)
• Strict confidentiality (proceeds under NDA)
• Services available nationwide (all 47 prefectures) and for all medical specialties

Please consult with us early, even if you only wish to understand market trends, lack a successor, or are considering joining a group.

Apply for a Free Consultation